Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details)

v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details) - Supplier Concentration Risk - Major vendors, combined
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Research and development expenditures          
Concentration          
Concentration Risk (as a percent) 44.00% 59.00% 44.00% 66.00%  
Accounts payable and accrued expense          
Concentration          
Concentration Risk (as a percent)     65.00%   54.00%